Turnstone Biologics Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Turnstone Biologics Corp.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 74% to $19,306,000. Profit margin reached -286%. Total operating expenses were $78,338,000.

Profit Margin

Turnstone Biologics Corp. (NASDAQ:TSBX): Profit margin
2021 101.29M 33.26M 32.84%
2022 73.3M -30.83M -42.07%
2023 19.30M -55.2M -285.92%

TSBX Income Statement (2021 – 2023)

2023 2022 2021
Revenue
Revenue
19.30M73.3M101.29M
Cost of revenue
2.8M00
Gross profit
16.50M73.3M101.29M
Operating exp.
Research and development
60.49M86.70M54.75M
Selling and marketing
000
Total operating expenses
78.33M104.92M68.3M
Operating income
-59.03M-31.62M32.99M
Other income (expenses), net
3.54M933K708K
Income before tax
-55.48M-30.69M33.70M
Income tax expense
-286K141K432K
Net income
-55.2M-30.83M33.26M
Earnings per share
Basic EPS
-4.77-1.391.5
Diluted EPS
-4.77-1.391.5
Data source